Santarus

Strong Drug Performance Boosts Santarus Higher

Strong Drug Performance Boosts Santarus Higher

Forbes

2 Biotech Companies With Strong Product Launches To Monitor

2 Biotech Companies With Strong Product Launches To Monitor

Seeking Alpha

Santarus Earnings Trounce Estimates; Stock Hits High

Santarus Earnings Trounce Estimates; Stock Hits High

Investors.com

Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery

Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery

Forbes

Santarus' Uceris Data Published

Santarus' Uceris Data Published

Yahoo/Zacks

4 Healthcare Stock Stories for Tuesday Investment Wellness

4 Healthcare Stock Stories for Tuesday Investment Wellness

Wall Street Cheat Street

Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes

Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes

Yahoo/BusinessWire

4 Healthcare Stock Stories for TGIF Wellness

4 Healthcare Stock Stories for TGIF Wellness

Wall Street Cheat Street

FDA Approval for Santarus' Uceris

FDA Approval for Santarus' Uceris

Yahoo/Zacks

Santarus Stock Pops To 8-Year High On Drug Approval

Santarus Stock Pops To 8-Year High On Drug Approval

Investors.com